Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh—A Case Report

Open Access

In Symposium articles, authors discuss a real-world problem, from the clinic, laboratory, or community, and how best it can be tackled.

Ulrika Marking,

Affiliation Médecins Sans Frontières, Amsterdam, The Netherlands
⨯
Margriet den Boer,

Affiliation Médecins Sans Frontières, Amsterdam, The Netherlands
⨯
Asish Kumar Das,

Affiliation Médecins Sans Frontières, Amsterdam, The Netherlands
⨯
Elshafie Mohamed Ahmed,

Affiliation Médecins Sans Frontières, Amsterdam, The Netherlands
⨯
Victoria Rollason,

Affiliation Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva, Geneva, Switzerland
⨯
Be-Nazir Ahmed,

Affiliation Communicable Disease Control, Directorate General of Health Services, Ministry of Health and Family Welfare, Dhaka, Bangladesh
⨯
Robert N. Davidson,

Affiliation Department of Infection and Tropical Medicine, Northwick Park Hospital, Harrow, United Kingdom
⨯
Koert Ritmeijer

* E-mail: koert.ritmeijer@amsterdam.msf.org

Affiliation Médecins Sans Frontières, Amsterdam, The Netherlands
⨯

Reader Comments (0)

Rhabdomyolysis
Is the Subject Area "Rhabdomyolysis" applicable to this article?

Thanks for your feedback.
Myalgia
Is the Subject Area "Myalgia" applicable to this article?

Thanks for your feedback.
Urine
Is the Subject Area "Urine" applicable to this article?

Thanks for your feedback.
Amphotericin
Is the Subject Area "Amphotericin" applicable to this article?

Thanks for your feedback.
Leishmaniasis
Is the Subject Area "Leishmaniasis" applicable to this article?

Thanks for your feedback.
Creatinine
Is the Subject Area "Creatinine" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.